비교리스트

 카트 문의
시장보고서
상품코드
1526403

세계의 멀티오믹스 시장 - 규모, 점유율, 동향, 산업 분석 보고서 : 제품 및 서비스별, 유형별, 플랫폼별, 용도별, 지역별, 부문별 예측(2024-2032년)

Multiomics Market Size, Share, Trends, Industry Analysis Report, By Product & Services (Products, and Services); By Type (Single-cell Multi-omics and Bulk Multi-omics); By Platform; By Application; By Region; Segment Forecast, 2024 - 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계 멀티오믹스 시장 규모는 2032년까지 86억 9,636만 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

멀티오믹스 시장은 의약품 개발의 강화나 종합적인 이해 등 다양한 이점이 있기 때문에 제약·바이오테크놀러지 기업에 의한 고도의 3D 멀티오믹스 프로파일링에 대한 투자가 증가하고 있는 것이 큰 요인이 되고 있습니다. 예를 들어, 2023년 11월, 멀티오믹스 기술을 제공하는 Stellaromics사는 3D 공간 멀티오믹스 프로파일링을 추진하기 위해 Series A 자금 조달로 2,500만 달러를 조달했습니다.

멀티오믹스에서 인공지능(AI), 머신러닝(ML), 사물인터넷(IoT)의 통합은 시장에 큰 기회를 만들어 냅니다. 이 기술은 데이터 통합, 자동화 및 의사 결정 프로세스를 개선합니다. AI와 ML 기술은 오믹스 기술의 도움으로 대량의 복잡한 데이터를 분석하고, 도표나 패턴의 도움으로 정확한 예측을 실시합니다. 예를 들어 2024년 3월, NVIDIA는 여러 오믹스 데이터 유형에 대응하는 AI 기술을 통합한 NVIDIA Parabricks v4.3을 발표했습니다. NVIDIA Parabricks v4.3은 생성형 AI를 사용하여 DNA, RNA, 메틸화, 단일 셀 및 공간 오믹 워크로드를 포함한 여러 오믹 데이터 유형을 분석합니다. 이러한 멀티오믹스 분야에서 AI의 통합은 예측 기간 동안 시장 수익을 높일 것으로 예상됩니다.

또한 클라우드 기반 소프트웨어의 채택이 증가함에 따라 멀티오믹스 데이터의 통찰력이 첨단 과학적 발견으로 전환됩니다. Google, SCIEX OS, PerkinElmer 등 시장 기업은 시장 경쟁력을 유지하기 위해 시장 성장 자금과 클라우드 기반 신제품 투입에 상당히 기여하고 있습니다. 예를 들어 2023년 6월 Form Bio와 Google Cloud는 'Google Cloud Multi-omics Suite'를 통해 멀티오믹스와 정밀의료를 제공하기 위해 제휴했습니다. 마찬가지로 2023년 5월 Google Cloud는 유전체 데이터 분석을 위한 AI를 갖춘 멀티오믹스 제품군을 발표했습니다.

싱글셀 오믹스 기술은 암 연구에 널리 이용되고 있습니다. 이 기술은 혈액 샘플 중 조기 종양, 희귀 암 세포 집단, 순환 종양 세포를 검출할 수 있습니다. 따라서 시장 관계자는 지속적으로 파트너십을 맺고 이 기술 수요를 충족하기 위해 신제품을 발표하고 있습니다. 예를 들어 2023년 6월 Honeycomb Biotechnologies & Revvity는 단일 셀 연구를 위한 새로운 솔루션 HIVE CLX를 출시했습니다. HIVE CLX 솔루션은 임상 연구자가 단일 셀 연구의 과제를 극복할 수 있도록 설계되었습니다.

멀티오믹스 시장 보고서 하이라이트

싱글셀 멀티오믹스 부문은 발생 생물학 및 조기 질환 진단을 위한 암 생물학에서의 이용에 의해 2023년에 가장 큰 시장 점유율을 차지했습니다.

대사체학 부문은 대사체학 플랫폼의 기술 진보로 예측 기간 동안 가장 높은 성장이 예상됩니다.

아시아태평양은 멀티오믹스 툴의 사용을 가능하게 하는 암 연구에 대한 투자 증가로 조사 기간 동안 가장 빠른 성장을 기록할 것으로 예측됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 멀티오믹스 시장 인사이트

  • 시장 현황
  • 멀티오믹스 시장 역학
    • 성장 촉진요인과 기회
      • 단일 세포 멀티오믹스의 기술적 진보
      • 연구개발에 대한 자금 증액
    • 억제요인과 과제
      • 첨단 유형에 높은 투자
  • PESTEL 분석
  • 멀티오믹스 시장 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 멀티오믹스 시장 : 제품 및 서비스별

  • 주요 조사 결과
  • 소개
  • 제품
  • 서비스

제6장 세계의 멀티오믹스 시장 : 유형별

  • 주요 조사 결과
  • 소개
  • 싱글셀 멀티오믹스
  • 벌크 멀티오믹스

제7장 세계의 멀티오믹스 시장 : 플랫폼별

  • 주요 조사 결과
  • 소개
  • 유전체학
  • 전사체학
  • 단백질체학
  • 대사체학
  • 통합 오믹스 플랫폼

제8장 세계의 멀티오믹스 시장 : 용도별

  • 주요 조사 결과
  • 소개
  • 세포 생물학
  • 종양학
  • 신경학
  • 면역학

제9장 세계의 멀티오믹스 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 멀티오믹스 시장 평가:지역별, 2019-2032년
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제10장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제11장 기업 프로파일

  • BD
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Danaher(Beckman Coulter)
  • PerkinElmer, Inc.
  • Shimadzu Corporation
  • Bruker
  • QIAGEN
  • Agilent Technologies, Inc.
  • BGI Genomics
JHS 24.08.22

The global multi-omics market size is expected to reach USD 8,696.36 Million by 2032, according to a new study by Polaris Market Research. The report "Multiomics Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Products, and Services); By Type (Single-cell Multi-omics, and Bulk Multi-omics); By Platform; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The multi-omics market is significantly driven by the increasing investment in advanced 3D multi-omics profiling by the pharmaceutical & biotechnology companies due to its various benefits, such as enhanced drug development and comprehensive understanding. For instance, in November 2023, Stellaromics, a provider of multi-omics technology, raised USD 25 million in series A funding to advance 3D spatial multi-omics profiling.

Integration of Artificial Intelligence (AI), Machine Learning (ML), and the Internet of Things (IoT) in multi-omics creates significant opportunities for the market. This technology improves data integration, automation, and decision-making processes. AI and ML technologies analyze large volumes of complex data with the help of omics technologies and make accurate predictions with the help of charts and patterns. For instance, in March 2024, NVIDIA introduced NVIDIA Parabricks v4.3 integrated with AI techniques for multiple omics data types. NVIDIA Parabricks v4.3 analyzes multiple omics data types, including DNA, RNA, methylation, single-cell, and spatial omics workloads, using generative AI. Such integration of AI in the multi-omics field is expected to drive the market revenue during the forecast period.

Furthermore, the increasing adoption of cloud-based software transforms multi-omics data insights into advanced scientific discoveries. The market players such as Google, SCIEX OS, and PerkinElmer are considerably contributing to the market growth funding and new cloud-based product launches, to stay competitive in the market. For instance, in June 2023, Form Bio and Google Cloud partnered to provide multi-omics and precision medicine through the "Google Cloud Multi-omics Suite." Similarly, in May 2023, Google Cloud launched an AI-powered multi-omics suite for the interpretation of genomic data.

Single-cell omics technologies are widely used in cancer research. This technology can detect early-stage tumours, rare cancer cell populations, and circulating tumour cells in blood samples. Therefore, market players are consistently forming partnerships and launching new products to meet the demand for this technology. For instance, in June 2023, Honeycomb Biotechnologies & Revvity launched a new solution, HIVE CLX, for single-cell research. The HIVE CLX solution is designed to enable clinical researchers to overcome challenges in single-cell studies.

Multi-omics Market Report Highlights

Single-cell multi-omics segment accounted for the largest market share in 2023, owing to its use in developmental biology, & cancer biology for early disease diagnosis.

The metabolomics segment is expected to witness the highest growth during the forecast period, owing to technological advancement in metabolomics platforms.

Asia Pacific is projected to register the fastest growth over the study period, attributable to growing investments in cancer research enabling the use of multi-omics tools.

The global players include BD, Thermo Fisher Scientific, Illumina, Inc., Danaher (Beckman Coulter), Perkin Elmer, Shimadzu Corporation, and Bruker

Polaris Market Research has segmented the multi-omics market report based on product & service, type, platform, application, and region:

Multiomics, Product & Service Outlook (Revenue - USD million, 2019 - 2032)

  • Products
  • Instruments
  • Consumables
  • Software
  • Services

Multiomics, Type Outlook (Revenue - USD million, 2019 - 2032)

  • Single-cell Multi-omics
  • Bulk Multi-omics

Multiomics, Platform Outlook (Revenue - USD million, 2019 - 2032)

  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms

Multiomics, Application Outlook (Revenue - USD million, 2019 - 2032)

  • Cell Biology
  • Oncology
  • Neurology
  • Immunology

Multiomics, Regional Outlook (Revenue - USD million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Multiomics Market Insights

  • 4.1. Multiomics Market - Market Snapshot
  • 4.2. Multiomics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Technological Advancements in Single-Cell Multi-Omics
      • 4.2.1.2. Increased Funding for Research and Development
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Investment in Advanced Type
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Multiomics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Multiomics Market, by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Multiomics Market, by Product & Service, 2019-2032 (USD Million)
  • 5.3. Products
    • 5.3.1. Global Multiomics Market, by Products, by Region, 2019-2032 (USD Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Global Multiomics Market, by Instruments, by Region, 2019-2032 (USD Million)
    • 5.3.3. Consumables
      • 5.3.3.1. Global Multiomics Market, by Consumables, by Region, 2019-2032 (USD Million)
    • 5.3.4. Software Artillery Shells
      • 5.3.4.1. Global Multiomics Market, by Software Artillery Shells, by Region, 2019-2032 (USD Million)
  • 5.4. Services
    • 5.4.1. Global Multiomics Market, by Services, by Region, 2019-2032 (USD Million)

6. Global Multiomics Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Multiomics Market, by Type, 2019-2032 (USD Million)
  • 6.3. Single-cell Multi-omics
    • 6.3.1. Global Multiomics Market, by Single-cell Multi-omics, by Region, 2019-2032 (USD Million)
  • 6.4. Bulk Multi-omics
    • 6.4.1. Global Multiomics Market, by Bulk Multi-omics, by Region, 2019-2032 (USD Million)

7. Global Multiomics Market, by Platform

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Multiomics Market, by Platform, 2019-2032 (USD Million)
  • 7.3. Genomics
    • 7.3.1. Global Multiomics Market, by Genomics, by Region, 2019-2032 (USD Million)
  • 7.4. Transcriptomics
    • 7.4.1. Global Multiomics Market, by Transcriptomics, by Region, 2019-2032 (USD Million)
  • 7.5. Proteomics
    • 7.5.1. Global Multiomics Market, by Proteomics, by Region, 2019-2032 (USD Million)
  • 7.6. Metabolomics
    • 7.6.1. Global Multiomics Market, by Metabolomics, by Region, 2019-2032 (USD Million)
  • 7.7. Integrated Omics Platforms
    • 7.7.1. Global Multiomics Market, by Other Integrated Omics Platforms, by Region, 2019-2032 (USD Million)

8. Global Multiomics Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Multiomics Market, by Application, 2019-2032 (USD Million)
  • 8.3. Cell Biology
    • 8.3.1. Global Multiomics Market, by Cell Biology, by Region, 2019-2032 (USD Million)
  • 8.4. Oncology
    • 8.4.1. Global Multiomics Market, by Oncology, by Region, 2019-2032 (USD Million)
  • 8.5. Neurology
    • 8.5.1. Global Multiomics Market, by Neurology, by Region, 2019-2032 (USD Million)
  • 8.6. Immunology
    • 8.6.1. Global Multiomics Market, by Immunology, by Region, 2019-2032 (USD Million)

9. Global Multiomics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Multiomics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Multiomics Market - North America
    • 9.3.1. North America: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
    • 9.3.2. North America: Multiomics Market, by Type, 2019-2032 (USD Million)
    • 9.3.3. North America: Multiomics Market, by Platform, 2019-2032 (USD Million)
    • 9.3.4. North America: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.3.5. Multiomics Market - U.S.
      • 9.3.5.1. U.S.: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.3.6. Multiomics Market - Canada
      • 9.3.6.1. Canada: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Multiomics Market, by Application, 2019-2032 (USD Million)
  • 9.4. Multiomics Market - Europe
    • 9.4.1. Europe: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
    • 9.4.2. Europe: Multiomics Market, by Type, 2019-2032 (USD Million)
    • 9.4.3. Europe: Multiomics Market, by Platform, 2019-2032 (USD Million)
    • 9.4.4. Europe: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.4.5. Multiomics Market - UK
      • 9.4.5.1. UK: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.4.6. Multiomics Market - France
      • 9.4.6.1. France: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.6.2. France: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.4.6.3. France: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.4.6.4. France: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.4.7. Multiomics Market - Germany
      • 9.4.7.1. Germany: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.4.8. Multiomics Market - Italy
      • 9.4.8.1. Italy: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.4.9. Multiomics Market - Spain
      • 9.4.9.1. Spain: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.4.10. Multiomics Market - Netherlands
      • 9.4.10.1. Netherlands: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.4.11. Multiomics Market - Russia
      • 9.4.11.1. Russia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.11.2. Russia: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.4.12. Multiomics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.12.2. Rest of Europe: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.4.12.3. Rest of Europe: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.4.12.4. Rest of Europe: Multiomics Market, by Application, 2019-2032 (USD Million)
  • 9.5. Multiomics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Multiomics Market, by Type, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Multiomics Market, by Platform, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.5.5. Multiomics Market - China
      • 9.5.5.1. China: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.5.2. China: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.5.5.3. China: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.5.5.4. China: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.5.6. Multiomics Market - India
      • 9.5.6.1. India: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.6.2. India: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.5.6.3. India: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.5.6.4. India: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.5.7. Multiomics Market - Malaysia
      • 9.5.7.1. Malaysia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.7.2. Malaysia: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.5.7.3. Malaysia: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.5.7.4. Malaysia: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.5.8. Multiomics Market - Japan
      • 9.5.8.1. Japan: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.8.2. Japan: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.5.8.3. Japan: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.5.8.4. Japan: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.5.9. Multiomics Market - Indonesia
      • 9.5.9.1. Indonesia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.5.10. Multiomics Market - South Korea
      • 9.5.10.1. South Korea: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.5.11. Multiomics Market - Australia
      • 9.5.11.1. Australia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.11.2. Australia: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.5.11.3. Australia: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.5.11.4. Australia: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.5.12. Multiomics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.12.2. Rest of Asia Pacific: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.5.12.3. Rest of Asia Pacific: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.5.12.4. Rest of Asia Pacific: Multiomics Market, by Application, 2019-2032 (USD Million)
  • 9.6. Multiomics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Multiomics Market, by Type, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Multiomics Market, by Platform, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.6.5. Multiomics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.6.6. Multiomics Market - UAE
      • 9.6.6.1. UAE: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.6.2. UAE: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.6.6.3. UAE: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.6.6.4. UAE: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.6.7. Multiomics Market - Israel
      • 9.6.7.1. Israel: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.6.8. Multiomics Market - South Africa
      • 9.6.8.1. South Africa: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.8.2. South Africa: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.6.8.3. South Africa: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.6.8.4. South Africa: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.6.9. Multiomics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.9.2. Rest of Middle East & Africa: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.6.9.3. Rest of Middle East & Africa: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.6.9.4. Rest of Middle East & Africa: Multiomics Market, by Application, 2019-2032 (USD Million)
  • 9.7. Multiomics Market - Latin America
    • 9.7.1. Latin America: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Multiomics Market, by Type, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Multiomics Market, by Platform, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.7.5. Multiomics Market - Mexico
      • 9.7.5.1. Mexico: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.7.6. Multiomics Market - Brazil
      • 9.7.6.1. Brazil: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.7.7. Multiomics Market - Argentina
      • 9.7.7.1. Argentina: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Multiomics Market, by Application, 2019-2032 (USD Million)
    • 9.7.8. Multiomics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Multiomics Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.8.2. Rest of Latin America: Multiomics Market, by Type, 2019-2032 (USD Million)
      • 9.7.8.3. Rest of Latin America: Multiomics Market, by Platform, 2019-2032 (USD Million)
      • 9.7.8.4. Rest of Latin America: Multiomics Market, by Application, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. BD
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Thermo Fisher Scientific, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Illumina, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Danaher (Beckman Coulter)
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. PerkinElmer, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Shimadzu Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Bruker
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. QIAGEN
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Agilent Technologies, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. BGI Genomics
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제